Efficacy of vedolizumab (VDZ) by disease localisation in Crohn's disease

被引：0
|
作者：
Allez, M. [1 ]
Braegger, F. [2 ]
Kempf, C. [2 ]
Michetti, P. [3 ,4 ]
机构：
[1] Univ Paris 07, Hop St Louis, AP HP, INSERM,UMRS 1160,Gastroenterol & Hepatol, Paris, France
[2] Takeda Pharmaceut Int AG, Zurich, Switzerland
[3] CHU Vaudois, Crohns & Colitis Ctr, Gastroenterol Source Beaulieu, Lausanne, Switzerland
[4] CHU Vaudois, Crohns & Colitis Ctr, Div Gastroenterol, Lausanne, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab
    Wichmann, Alana
    Cleveland, Noa Krugliak
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (04): : 577 - 577
  • [42] Idiopathic Angioedema Associated with Crohn's Disease: Response to Vedolizumab
    Mason, Matthew
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 : S12 - S12
  • [43] Metastatic Crohn disease improving with vedolizumab
    Costa Blasco, Marta
    McFeely, Orla
    Doyle, Claire
    Wolinska, Anna
    Andrawis, Madonna
    Murphy, Lisa
    Beatty, Paula
    O'Mahony, Sarah
    Hackett, Caitriona
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : E35 - E35
  • [44] Current position on Vedolizumab for ulcerative colitis and Crohn's disease
    Schreiber, S.
    Dignass, A. U.
    Hartmann, H.
    Kruis, W.
    Rogler, G.
    Siegmund, B.
    Stallmach, A.
    Witte, C.
    Bokemeyer, B.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (06): : 591 - 602
  • [45] Gastroenterology Vedolizumab as an Option in ulcerative Colitis and Crohn's Disease?
    Pommer, Peter
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (45) : 2284 - 2284
  • [46] Transmural healing with vedolizumab in patients with active Crohn's disease
    Rimola, J.
    Colombel, J. F.
    Bressler, B.
    Adsul, S.
    Siegelman, J.
    Cole, P. E.
    Lindner, D.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S053 - S056
  • [47] Vedolizumab in the treatment of Crohn's disease: A promising therapeutic approach
    Zargar, Abrar Ahmad
    [J]. DRUG DEVELOPMENT RESEARCH, 2024, 85 (04)
  • [48] Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6
    Sandborn, W. J.
    Feagan, B.
    Reinisch, W.
    Smyth, M.
    Xu, J.
    Parikh, A.
    Fox, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S274 - S275
  • [49] Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease
    Hirten, Robert
    Longman, Randy S.
    Bosworth, Brian P.
    Steinlauf, Adam
    Scherl, Ellen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (12): : 1737 - 1738
  • [50] Vedolizumab vs TNF antagonists in patients with Crohn's disease
    [J]. Reactions Weekly, 2020, 1814 (1) : 12 - 12
12345